This retrospective study of 382 extremity and truncal soft tissue sarcoma patients asked whether margin width — not just margin status — affects outcomes when radiotherapy is used. All patients underwent limb-sparing surgery with radiotherapy at a single institution over 27 years. The study examined whether a 1 mm negative margin performs differently from a 5 mm or wider margin.
1–5 mm: 93%
5 mm: 100%
The clinical tension this paper addresses is real: when a sarcoma abuts a femoral nerve or popliteal vessels, how aggressively must you chase the margin? This study provides a data-supported answer for the RT-treated patient: once the margin is negative (tumor not at ink), making it wider does not improve local control or survival.
The practical implication is that sacrificing function to achieve a wider margin is not justified in patients receiving RT. A 1 mm negative margin along a critical structure, combined with radiotherapy, is oncologically equivalent to a 5 mm margin.
Two important caveats shape how you use this paper. First, margin quality matters: the authors note that a 1 mm fascial margin outperforms a 5 mm fat margin because fascia is a superior tumor barrier — millimeter width alone is an incomplete metric.
Second, this is a surgery-plus-RT dataset. For patients managed with surgery alone — a minority at specialized centers but a real scenario — wider margins may remain necessary, and this data does not apply.
This retrospective study of 382 extremity and truncal soft tissue sarcoma patients asked whether margin width — not just margin status — affects outcomes when radiotherapy is used. All patients underwent limb-sparing surgery with radiotherapy at a single institution over 27 years. The study examined whether a 1 mm negative margin performs differently from a 5 mm or wider margin.
1–5 mm: 93%
5 mm: 100%
The clinical tension this paper addresses is real: when a sarcoma abuts a femoral nerve or popliteal vessels, how aggressively must you chase the margin? This study provides a data-supported answer for the RT-treated patient: once the margin is negative (tumor not at ink), making it wider does not improve local control or survival.
The practical implication is that sacrificing function to achieve a wider margin is not justified in patients receiving RT. A 1 mm negative margin along a critical structure, combined with radiotherapy, is oncologically equivalent to a 5 mm margin.
Two important caveats shape how you use this paper. First, margin quality matters: the authors note that a 1 mm fascial margin outperforms a 5 mm fat margin because fascia is a superior tumor barrier — millimeter width alone is an incomplete metric.
Second, this is a surgery-plus-RT dataset. For patients managed with surgery alone — a minority at specialized centers but a real scenario — wider margins may remain necessary, and this data does not apply.